SQZ Biotechnologies Co·4

Jan 26, 4:45 PM ET

Knopf Lawrence J 4

4 · SQZ Biotechnologies Co · Filed Jan 26, 2023

Insider Transaction Report

Form 4
Period: 2023-01-24
Knopf Lawrence J
General Counsel
Transactions
  • Award

    Stock Option

    2023-01-24+227,000227,000 total
    Exercise: $0.73Exp: 2033-01-24Common Stock (227,000 underlying)
Footnotes (1)
  • [F1]The option vests and becomes exercisable as to 25% of the underlying securities on January 24, 2024 and in 36 substantially equal monthly installments thereafter, subject to limited acceleration upon involuntary termination.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION